| Literature DB >> 27869658 |
Sajid Rauf1, Muhammad Azhar Hayat Nawaz2, Mihaela Badea3, Jean Louis Marty4, Akhtar Hayat5,6.
Abstract
Diabetes is a rapidly growing disease that can be monitored at an individual level by controlling the blood glucose level, hence minimizing the negative impact of the disease. Significant research efforts have been focused on the design of novel and improved technologies to overcome the limitations of existing glucose analysis methods. In this context, nanotechnology has enabled the diagnosis at the single cell and molecular level with the possibility of incorporation in advanced molecular diagnostic biochips. Recent years have witnessed the exploration and synthesis of various types of nanomaterials with enzyme-like properties, with their subsequent integration into the design of biomimetic optical sensors for glucose monitoring. This review paper will provide insights on the type, nature and synthesis of different biomimetic nanomaterials. Moreover, recent developments in the integration of these nanomaterials for optical glucose biosensing will be highlighted, with a final discussion on the challenges that must be addressed for successful implementation of these nano-devices in the clinical applications is presented.Entities:
Keywords: biomimetic nanomaterials; diabetes; glucose monitoring; nanotechnology; optical sensors
Mesh:
Substances:
Year: 2016 PMID: 27869658 PMCID: PMC5134590 DOI: 10.3390/s16111931
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Classification of nanomaterial-based artificial enzymes (nanozymes).
Figure 2Colorimetric detection of H2O2 and glucose based on Fe3O4 nanozyme as peroxidase mimic.
Figure 3Ceria Paper based, colorimetric glucose sensor, color change of nanoceria-based filter paper from white (1)-yellow (2) to dark orange (3) [70].
Figure 4Colorimetric detection of glucose by using glucose oxidase (GOx) and a Cu NCs-catalyzed color reaction [91].
Analytical performance comparison of the single component nanozyme methods for the detection of glucose.
| Nanozymes | Limit of Detection (LOD) | Linear Range | Real Sample Test | Ref |
|---|---|---|---|---|
| Fe3O4 MNPs | 30 µM | 50–1 × 103 µM | N/A | [ |
| Positively-charged AuNPs | 4 µM | 18–1100 µM | N/A | [ |
| Nanoceria | 500 µM | 5 × 102–1 × 105 µM | Human Serum | [ |
| C-dots | 0.4 µM | 1–5 × 102 µM | Human Serum | [ |
| Water soluble CuO NPs | N/A | 1 × 102–8 × 103 µM | N/A | [ |
| Re-dispersed CeO2 NPs | 3 µM | 6.6–130 µM | Human Serum | [ |
| Copper nanoclusters | 100 µM | 1 × 102–2 × 103 µM | N/A | [ |
| Ag nanoplates | 0.2 µM | 0.2–1 × 102 µM | Human Serum | [ |
| AuNPs | 49 µM | 1 × 102–1 × 103 µM | Human Serum | [ |
| MPs | 3.74 µM | N/A | N/A | [ |
Figure 5Colorimetric detection of glucose by using GOx catalyzed reaction (A) and Pt-MoO3 hybrid nanomaterials as catalysts (B) [118].
Analytical performance comparison of the multi component nanozyme methods for the detection of glucose.
| Nanozymes | Limit of Detection (LOD) | Linear Range | Real Sample Test | Ref |
|---|---|---|---|---|
| GO-COOH | 1 µM | 1–20 µM | Human Serum, juices | [ |
| Ch-Ag NPs | 0.1 µM | 5–200 µM | Human Serum | [ |
| PDDA-Fe2O3 | 30 µM | 30–1 × 103 µM | Human Serum | [ |
| ZnFe2O4 MNPs | 0.3 µM | 1.25–18.75 µM | Urine sample | [ |
| C60[C(COOH)2]2 | 0.5 µM | N/A | Human Serum | [ |
| PB-Fe2O3 | 0.16 µM | 1–80 µM | Human Serum | [ |
| Fe3O4@MSN | 4 µM | 10–500 µM | N/A | [ |
| GQDs/AgNPs | 0.17 µM | 0.5–400 µM | N/A | [ |
| CF nano-cubes | 2.47 µM | 8–90 µM | Human Serum | [ |
| Apoferritin paired gold clusters (Au-Ft) | N/A | 2 × 103–1 × 104 µM | N/A | [ |
| DNA-embedded core-shell Au@Ag NPs | 0.01 µM | 0–2 × 102 µM | Fetal bovine serum | [ |
| FeSe-Pt@SiO2 nanospheres | 1.136 nM | 0.01136–227 µM | Human Serum | [ |
| V2O3-OMC | 3.3 µM | 10–4 × 103 µM | Serum | [ |
| Janus γ-Fe2O3/SiO2 NPs | 3.2 µM | 0–20 µM | Human Serum | [ |
| H2TCPP-NiO nanocomposites | 20 µM | 50–5 × 102 µM | N/A | [ |
| Nitrogen-doped graphene quantum dots | 16 µM | 25–375 µM | Serum | [ |
| Pt-MoO3 hybrid nanomaterials | 0.1874 µM | 5–500 µM | Serum | [ |